Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flibanserin in Younger Women With HSDD
NCT00277914Phase 3Completed
- Sponsor
- Sprout Pharmaceuticals
- Start
- Jan 2006
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in hypoactive sexual desire disorder (HSDD) comparing Flibanserin with Placebo (2 arms). Primary endpoint: Sexually Satisfying Events at 24 weeks. Started Jan 2006; status: completed.
02
Drugs
flibanserin
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT00277914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277914.